Trademark: 79165660
Status Date
Thursday, December 1, 2022
Registration Number
4961987
Registration Date
Tuesday, May 24, 2016
Filing Date
Wednesday, February 25, 2015
Published for Opposition
Tuesday, March 8, 2016
41 [Education and training services, namely, providing classes, seminars, conferences, lectures and workshops in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; education services, namely, providing non-downloadable electronic publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care; provision of non-downloadable electronic publications, namely, newsletters, articles, brochures and booklets in the field of pharmaceuticals, health care, health insurance, medical information, bleeding disorders or conditions, hemophilia, hematology, immunology, oncology and patient care]
9 [Computer software for use in the inputting of patient information for transmission to health care professionals; computer software for use in calculating and tailoring the optimal dosage for patients; computer application software for recording and analyzing patient information; computer application software, namely, software for tracking and managing patients' medication and wellness; computer software for tracking and managing pharmaceutical infusions and physical conditions of patients with bleeding disorders; computer software program for mobile phones, tablets, hand held devices and computers for tracking patient information and providing educational information in the field of hemophilia treatment options, designed for patients and health care professionals; downloadable electronic publications, namely, newsletters, articles, brochures, booklets, white papers and presentations in the field of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care]
5 Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents
16 [Printed publications for teaching, namely, brochures, booklets, training manuals and teaching materials, newsletters and white papers in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care; printed publications, namely, brochures, booklets, training manuals and teaching materials, newsletters and white papers in the fields of pharmaceuticals, health care, health insurance, medical information, bleeding conditions, hemophilia, hematology, immunology, oncology and patient care; publications, namely, printed instructional and educational guides featuring information about bleeding conditions]
38 [Provision of access to computer databases containing medical information related to hematological, immunological and oncological diseases, disorders and treatment]
44 [Medical services and health care; health care services, namely, providing care for human health; medical services, namely, human blood component collection services; medical services, namely, blood purification; medical services, namely, providing medical information in the field of oncology, immunology and hematology via a website; providing an online database for identifying the optimal dosage of medications for patients; medical services, namely, providing free trial prescription service programs for pharmaceutical preparations for the treatment of blood disorders]
10 Medical devices, namely, devices for reconstituting dried pharmaceuticals; medical apparatus and instruments, namely, medical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations
Oct 15, 2023
Partial Invalidation Processed By The Ib
Aug 30, 2023
Partial Invalidation Of Reg Ext Protection Sent To Ib
Aug 30, 2023
Invalidation Processed
Aug 1, 2023
Partial Invalidation Of Reg Ext Protection Created
Dec 1, 2022
Notice Of Acceptance Of Sec. 71 - E-Mailed
Dec 1, 2022
Registered - Partial Sec 71 Accepted
Nov 7, 2022
Case Assigned To Post Registration Paralegal
Oct 22, 2022
New Representative At Ib Received
Oct 21, 2022
New Representative At Ib Received
May 23, 2022
Teas Section 71 Received
May 24, 2021
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Apr 8, 2017
Final Decision Transaction Processed By Ib
Sep 15, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 25, 2016
Final Disposition Notice Sent To Ib
Aug 25, 2016
Final Disposition Processed
Aug 24, 2016
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2016
Registered-Principal Register
Mar 8, 2016
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2016
Published For Opposition
Mar 4, 2016
Notification Processed By Ib
Feb 17, 2016
Notification Of Possible Opposition Sent To Ib
Feb 17, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 17, 2016
Notification Of Notice Of Publication E-Mailed
Feb 3, 2016
Law Office Publication Review Completed
Jan 27, 2016
Approved For Pub - Principal Register
Jan 15, 2016
Teas/Email Correspondence Entered
Jan 14, 2016
Correspondence Received In Law Office
Jan 14, 2016
Teas Request For Reconsideration Received
Jan 11, 2016
Notification Of Final Refusal Emailed
Jan 11, 2016
Final Refusal E-Mailed
Jan 11, 2016
Final Refusal Written
Dec 19, 2015
Teas/Email Correspondence Entered
Dec 19, 2015
Correspondence Received In Law Office
Dec 19, 2015
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 18, 2015
Assigned To Lie
Dec 4, 2015
Teas Response To Office Action Received
Nov 19, 2015
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 19, 2015
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 1, 2015
New Representative At Ib Received
Jul 31, 2015
Change Of Owner Received From Ib
Jun 27, 2015
Refusal Processed By Ib
Jun 9, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Jun 9, 2015
Refusal Processed By Mpu
Jun 6, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Jun 5, 2015
Non-Final Action Written
Jun 5, 2015
Application Filing Receipt Mailed
Jun 2, 2015
Assigned To Examiner
Jun 1, 2015
New Application Office Supplied Data Entered
May 30, 2015
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
